Stretch Marks Treatment Market

Market Overview:

The global stretch marks treatment market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome. Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.

Stretch Marks Treatment Market Trends:

The increasing incidence of obesity among the masses is one of the key factors driving the market growth. With the changing dietary patterns and the rising adoption of sedentary lifestyles, individuals are widely suffering from excessive weight gain, which is leading to the development of stretch marks. Moreover, the increasing product demand among pregnant women is favoring the market growth. Stretch marks lotions, oils and serums are fortified with essential oils and nutrients that aid in minimizing the visibility of stretched and broken skin and promote healing. Additionally, various product innovations, such as the launch of chemical peels, platelet-rich plasma (PRP), micro-needling, non-invasive microdermabrasion and laser-based treatment procedures, are providing a thrust to the market growth. These procedures aid in the breakdown of old collagen and promote the development of new skin tissues. Other factors, including the convenient availability of over-the-counter stretch marks ointments, along with the increasing consciousness among the masses regarding their physical appearance, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global stretch marks treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on treatment, distribution channel and end user.

Breakup by Treatment:

• Topical Products
  • Creams
  • Oils and Serum
  • Lotions
• Lasers
  • Fractional Lasers
  • Pulse-Dye Lasers
  • Others
• Microdermabrasion
• Others
   

Breakup by Distribution Channel:

• Institutional
• Retail
  • Supermarkets and Hypermarkets
  • Specialist Retailers
  • Medical Retailers
  • Online Stores
  • Others
     

Breakup by End User:

• Hospitals and Clinics
• Home Use
• Specialty Dermatology Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.

Report Coverage: